Deepdive – Market Access

Pharma market access has been a key focus for pharmaphorum ever since the company was founded 12 years ago, but it’s fair to say there has never been a more interesting time for the area than now.

Not only has COVID forced companies, governments and healthcare systems to work towards approving drugs and vaccines in record times, the sector is also facing an influx of digital therapeutics and advanced drugs that don’t fit neatly into existing access frameworks.

We take a look at all these intersecting topics in this issue of Deep Dive – with experts from across the industry sharing their predictions for the future and their advice on how companies can navigate these paradigm shifts.